Covid-19

BioData free video conferencing enables COVID-19 collaboration

06-Apr-2020 By Jenni Spinner

The company has integrated a video conferencing and documentation tool to its Labguru electronic laboratory notebook at no charge during the pandemic.

Saama launches COVID-19 data collaboration

06-Apr-2020 By Jenni Spinner

The company’s EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus.

Science 37 guide offers COVID-19 advice for trials

06-Apr-2020 By Jenni Spinner

The whitepaper features guidance on moving forward with clinical research while working to avoid risks to patient safety and business interruption.

Advarra presents free clinical research resources during COVID-19 crisis

02-Apr-2020 By Jenni Spinner

The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory software and more.

FDA updates and actions on COVID-19

01-Apr-2020 By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.

MedPharm donates hand sanitizer to combat COVID-19

31-Mar-2020 By Jenni Spinner

The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus.

Developer seeks collaborators to advance potential coronavirus treatment

30-Mar-2020 By Vassia Barba

Bold is on the hunt for supporters among the industry to help evaluate its investigational anti-cancer therapy as a potential coronavirus treatment, after seeing related elements.

FDA grants chloroquine emergency authorization as coronavirus treatment

30-Mar-2020 By Vassia Barba

The US FDA has issued the first emergency use authorization to chloroquine phosphate and hydroxychloroquine sulfate as treatments against coronavirus.

Gates Foundation enlists Novartis, GSK, others in COVID-19 fight

27-Mar-2020 By Jenni Spinner

The global collaboration brings together several pharmaceutical giants to accelerate the development and delivery of coronavirus tests and therapies.

FDA roundup of COVID-19 responses

25-Mar-2020 By Jenni Spinner

The federal agency has been busy in recent weeks, taking actions and issuing advice in the face of the global coronavirus pandemic.

FDA lifts import alert on Ipca Labs for chloroquine supply

24-Mar-2020 By Ben Hargreaves

In order to boost the supply of chloroquine, the US FDA has allowed Ipca to supply APIs and finished product to the country.

Trial management service available for free amid COVID-19 pandemic

23-Mar-2020 By Vassia Barba

Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.